MIRA INFORM REPORT

 

 

Report Date :

13.03.2012

 

IDENTIFICATION DETAILS

 

Name :

ENAL DRUGS PRIVATE LIMITED

 

 

Registered Office :

Plot No. 136, Phase-1, Kalyan Nagar, Hyderabad – 500038, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

27.06.1990

 

 

Com. Reg. No.:

01-011422

 

 

Capital Investment / Paid-up Capital :

Rs.9.827 Millions

 

 

CIN No.:

[Company Identification No.]

U24230AP1990PTC011422

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDE00420A

 

 

PAN No.:

[Permanent Account No.]

AAACE4424F

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharma Chemicals.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (47)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 240000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LOCATIONS

 

Registered Office :

Plot No. 136, Phase-1, Kalyan Nagar, Hyderabad – 500038, Andhra Pradesh, India

Tel. No.:

91-40-44753636/ 23193623/ 23193624/625

Fax No.:

91-40-23096953

E-Mail :

accounts@enaldrugs.com

enaldrugs@satyam.net.in

mktg@enaldrugs.com

purchase@enaldrugs.com

Website :

www.enaldrugs.com

 

 

Factory :

D-33,34,35, Phase-I, IDA, Jeedimetla, Hyderabad – 500055, Andhra Pradesh, India

 

 

DIRECTORS

 

As on 28.09.2011

 

Name :

Mr. Suresh Babu Sunkaraneni

Designation :

Managing Director

Address :

Plot No. 136, Phase-1, Kalyan Nagar, Hyderabad – 500038, Andhra Pradesh, India

Date of Birth/Age :

02.10.1960

Date of Appointment :

27.06.1990

DIN No.:

00127565

Other Directorship :

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24230AP1990PTC011422

ENAL DRUGS PRIVATE LIMITED

Managing director

27/06/1990

27/06/1990

-

Active

NO

2

U23201AP1991PTC012561

GODAVARI LUBRICANTS PRIVATE LIMITED

Director

1/12/2007

1/12/2007

3/06/2008

Active

NO

3

U24232AP2011PTC076566

ENAL PHARMACHEM PRIVATE LIMITED

Director

16/09/2011

16/09/2011

-

Active

NO

 

 

Name :

Uma Sunkaraneni

Designation :

Director

Address :

Plot No. 136, Phase-1, Kalyan Nagar, Hyderabad – 500038, Andhra Pradesh, India

Date of Birth/Age :

11.07.1966

Date of Appointment :

07.11.1994

DIN No.:

00390992

Other Directorship :

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24230AP1990PTC011422

ENAL DRUGS PRIVATE LIMITED

Director

7/11/1994

7/11/1994

-

Active

NO

2

U23201AP1991PTC012561

GODAVARI LUBRICANTS PRIVATE LIMITED

Director

1/12/2007

1/12/2007

3/06/2008

Active

NO

3

U24232AP2011PTC076566

ENAL PHARMACHEM PRIVATE LIMITED

Director

16/09/2011

16/09/2011

-

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 28.09.2011

 

Names of Shareholders

 

No. of Shares

S. Suresh Babu

 

536864

S. Uma

 

405002

Shruti

 

30000

S. Sudhakar

 

4000

A. Surender Reddy

 

6800

Total

 

982666

 

 

Equity Share Break up (Percentage of Total Equity)

As on 28.09.2011

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharma Chemicals.

 

 

Products :

Omeprazole, Lansoprazole, Intermediates

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

·         State Bank of Mysore, Manjula Apartments, JNTU Road, KPHB Colony, Kukatpally, Hyderabad – 500072, Andhra Pradesh, India

·         State Bank of Mysore, RASMECCC,  1st Floor, 2-1-340/16, Sai Tara Towers, Nallakunta Chowrasta, Hyderabad – 500044, Andhra Pradesh, India

·         HDFC Bank

 

 

Facilities :

Secured Loan

As on 31.03.2011

(Rs. in Millions)

As on 31.03.2010

(Rs. in Millions)

Secured OD

(Secured by way of hypothecation of  plant and machinery, Stock and Debtors)

35.537

40.763

Term Loan with SBM

(Secured by way of hypothecation of  plant and machinery, Stock and Debtors)

15.716

9.336

Reliance Capital – Eicher

0.099

0.465

Reliance Capital – Eicher  2

0.922

0.000

Reliance Capital – Tata Ace

0.288

0.000

HDFC - Innova

0.696

1.000

HDFC – Aveo

0.396

0.549

HDFC – I 20

0.443

0.000

HDFC Venu

0.570

0.790

HDFC – Swift Dzire

0.357

0.000

SIDBI

3.152

0.000

Total

58.176

52.903

 

Unsecured Loan

As on 31.03.2011

(Rs. in Millions)

As on 31.03.2010

(Rs. in Millions)

ABN Amro Loan

0.000

0.240

Bajaj Finance Limited

2.500

0.709

HDFC Business Loan

2.000

0.000

Kotak Mahindra Bank Limited

1.865

0.000

Total

6.365

0.949

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

K Vishwanath and Company

Chartered Accountants

Address :

6-3-11/4/D, Somajiguda, Rajbhavan Road, Hyderabad – 500082, Andhra Pradesh, India

PAN.:

AAGFK5188B

 

 

CAPITAL STRUCTURE

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

1000000

Equity Shares

Rs.10/- each

Rs.10.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

982666

Equity Shares

Rs.10/- each

Rs.9.827 Millions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

9.827

9.827

9.827

2] Share Application Money

10.300

0.000

0.000

3] Reserves & Surplus

41.159

30.456

20.880

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

61.286

40.283

30.707

LOAN FUNDS

 

 

 

1] Secured Loans

58.176

52.903

32.984

2] Unsecured Loans

6.365

0.949

1.867

TOTAL BORROWING

64.541

53.852

34.851

DEFERRED TAX LIABILITIES

0.619

0.519

0.000

 

 

 

 

TOTAL

126.446

94.654

65.558

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

61.749

42.093

40.204

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.050

0.050

0.050

DEFERREX TAX ASSETS

0.000

0.000

0.603

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

42.286

20.938

21.276

 

Sundry Debtors

106.327

89.923

43.333

 

Cash & Bank Balances

0.093

0.087

2.753

 

Other Current Assets

2.710

11.977

0.000

 

Loans & Advances

32.100

19.996

9.161

Total Current Assets

183.516

142.921

76.523

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

84.057

57.191

36.014

 

Other Current Liabilities

10.221

13.170

4.977

 

Provisions

24.591

20.049

10.831

Total Current Liabilities

118.869

90.410

51.822

Net Current Assets

64.647

52.511

24.701

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

126.446

94.654

65.558

 

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

307.343

272.294

136.765

 

 

Other Income

5.147

1.497

0.103

 

 

Foreign Exchange Variation

0.287

0.078

0.408

 

 

TOTAL                                     (A)

312.777

273.869

137.276

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Increase/ (Decrease) Stock

(18.079)

4.107

(6.185)

 

 

Raw Material Consumed

200.471

150.422

79.461

 

 

Factory Expenses

49.018

39.513

25.713

 

 

Selling and Administrative Expenses

55.529

56.589

37.985

 

 

Deferred Tax Asset/ Liability

0.000

0.000

(0.176)

 

 

TOTAL                                     (B)

286.939

250.631

136.798

 

 

 

 

 

Less

PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

25.838

23.238

0.478

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

25.838

23.238

0.478

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

9.036

6.539

6.150

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)                 (G)

16.802

16.699

(5.672)

 

 

 

 

 

Less

TAX                                                                  (H)

6.099

7.123

NA

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX (G-H)                  (I)

10.703

9.576

NA

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

10.89

15.85

(5.77)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

3.42

3.50

NA

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

5.47

6.13

4.15

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

6.85

9.02

4.86

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.27

0.41

0.18

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

2.99

3.58

2.82

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.54

1.58

1.48

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Bankers Charges Report as per Registry

 

Corporate identity number of the company

U24230AP1990PTC011422

Name of the company

ENAL DRUGS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Plot No 136, Phase-1kalyan Nagar, Hyderabad – 500038, Andhra Pradesh, India

Email : accounts@enaldrugs.com

This form is for

Creation of charge

Type of charge

  • Book Debts
  • Movable Property

Particular of charge holder

State Bank of Mysore, RASMECCC,  1st Floor, 2-1-340/16, Sai Tara Towers, Nallakunta Chowrasta, Hyderabad – 500044, Andhra Pradesh, India

Email: rasmeccchyd@sbm.co.in

Nature of instrument creating charge

Letter of Arrangement

Supplemental Agreement of loan cum Hypothecation

Deed of Guarantee

Date of instrument Creating the charge

02.11.2010

Amount secured by the charge

Rs.10.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

14% pa payment with monthly rests.

 

Terms of Repayment

60 monthly installments of Rs.0.167 million each commencing from December 2010 and the last installment on December 2015.

 

Margin

Finished Goods : 22%

 

Extent and Operation of the charge

First charge on current assets and fixed assets both present and future of the Company.

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Equitable mortgage of Plot No.33, Phase-1, IDA, Jeedimetla (vii).

 

Equitable mortgage of 4-165/7 on Plot No-78 at Old Alwal Municipality, Malkajgiri, RR District

 

Equitable mortgage of Plot No.34 and D-35 on Sy.No.284/2, Phase -1, IDA Jeedimetla, Quthubullapur (Mandal), RR District

 

FIXED ASSETS

 

  • Land
  • Building
  • Plant and Machinery
  • Furniture and Fixture
  • Office Equipment
  • Computers
  • Lab Equipment
  • Electrical Equipment
  • Factory Equipment
  • Vehicle
  • Air Conditioner              

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.49.94

UK Pound

1

Rs.78.25

Euro

1

Rs.65.40

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

47

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.